Cover Image
市場調查報告書

止血劑·組織密封膠的全球市場:2016年∼2020年

Global Hemostats and Tissue Sealants Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 361449
出版日期 內容資訊 英文 66 Pages
訂單完成後即時交付
價格
Back to Top
止血劑·組織密封膠的全球市場:2016年∼2020年 Global Hemostats and Tissue Sealants Market 2016-2020
出版日期: 2016年06月09日 內容資訊: 英文 66 Pages
簡介

全球止血劑·組織密封膠市場預測在2016年∼2020年將以年複合成長率 (CAGR) 8.72%的速度成長。

本報告提供全球止血劑·組織密封膠市場相關調查分析,提供您市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

第1章 摘要整理

  • 焦點

第2章 調查範圍

  • 市場概要
  • 主要供應商產品

第3章 市場調查手法

  • 調查手法
  • 經濟指標

第4章 簡介

  • 主要市場焦點
  • 凝固

第5章 止血劑·組織密封膠的市場形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 止血劑·組織密封膠的市場區隔:各產品

第7章 全球止血劑市場

第8章 全球組織密封膠市場

第9章 止血劑·組織密封膠的地理位置區分

  • 地理位置區分
  • 南北美洲
  • 歐洲·中東·非洲
  • 亞太地區

第10章 止血劑·組織密封膠市場推動因素

第11章 推動因素的影響

第12章 止血劑·組織密封膠市場課題

第13章 推動因素與課題的影響

第14章 止血劑·組織密封膠的市場趨勢

第15章 業者情勢

  • 競爭模式
  • 市場佔有率分析
  • Advanced Medical Solutions Group
  • Baxter International
  • C. R. Bard
  • CryoLife
  • CSL Behring
  • Integra LifeSciences
  • Johnson & Johnson (Ethicon)
  • 其他卓越供應商

第16章 附錄

  • 簡稱清單

第17章 關於Technavio

目錄
Product Code: IRTNTR8388

About the Hemostats and Tissue Sealants Market

Blood clotting or coagulation, is an important process that eliminates excessive bleeding when a blood vessel is damaged. Platelets and proteins work together to stop the bleeding by forming a clot over the injury. Blood clottage is one of the mechanisms that reduce the loss of blood from damaged blood vessels.

Hemostats and tissue sealants are used post-surgery or traumatic injury to bind or hold external tissue (skin) as well as internal tissue (blood vessels). Some key types of hemostats and tissue sealants include fibrin sealants, collagen-based compounds, synthetic agents, and tissue adhesive glues such as hydrogels and glutaraldehyde glues. Fibrin sealants have a wide range of medical applications.

Technavio's analysts forecast the global hemostats and tissue sealants market to grow at a CAGR of 8.72% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global hemostats and tissue sealants market for 2016-2020. To calculate the market size, Technavio uses revenue generated from the following products:

  • Topical hemostats (active hemostats, mechanical hemostats, and flowable hemostats)
  • Tissue sealants (fibrin and synthetic sealants)

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Hemostats and Tissue Sealants Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Advanced Medical Solutions Group
  • Baxter International
  • C. R. Bard
  • Cryolife
  • CSL Behring
  • Integra LifeSciences
  • Johnson & Johnson (Ethicon)

Other Prominent Vendors

  • B. Braun
  • Cardinal Health
  • Cohera Medical
  • Haemacure
  • HyperBranch Medical Technology
  • NeoMend
  • Smith & Nephew
  • Teijin Pharma
  • Tissuemed
  • Vascular Solutions
  • Vivostat
  • Z-Medica

Market driver

  • Focus on patient safety and quicker recovery
  • For a full, detailed list, view our report

Market challenge

  • Paucity of ready-to-use products
  • For a full, detailed list, view our report

Market trend

  • Approval of fibrin sealants as broad level hemostats
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights
  • Coagulation

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by product

PART 07: Global hemostats market

PART 08: Global tissue sealants market

PART 09: Geographical segmentation

  • Geographical segmentation of global hemostats and tissue sealants market
  • Hemostats and tissue sealants market in Americas
  • Hemostats and tissue sealants market in EMEA
  • Hemostats and tissue sealants market in APAC

PART 10: Market drivers

PART 11: Impact of drivers

PART 12: Market challenges

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape

  • Competitive scenario
  • Market share analysis 2015
  • Advanced Medical Solutions Group
  • Baxter International
  • C. R. Bard
  • CryoLife
  • CSL Behring
  • Integra LifeSciences
  • Johnson & Johnson (Ethicon)
  • Other prominent vendors

PART 16: Appendix

PART 17: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Process of coagulation
  • Exhibit 03: Mechanism of blood coagulation
  • Exhibit 04: Global hemostats and tissue sealants market
  • Exhibit 05: Global hemostats and tissue sealants market 2015-2020 ($ billions)
  • Exhibit 06: Five forces analysis
  • Exhibit 07: Segmentation of global hemostats and tissue sealants market by product type
  • Exhibit 08: Segmentation of global hemostats and tissue sealants market by product type 2015
  • Exhibit 09: Segmentation of global hemostats and tissue sealants market by product type 2020
  • Exhibit 10: Segmentation of global hemostats and tissue sealants market by product type 2015-2020
  • Exhibit 11: Global hemostats market 2015-2020 ($ billions)
  • Exhibit 12: Segmentation of global hemostats market by type of product 2015
  • Exhibit 13: Categorization of active hemostats
  • Exhibit 14: Categorization of mechanical hemostats
  • Exhibit 15: Categorization of flowable hemostats
  • Exhibit 17: Global tissue sealants market 2015-2020 ($ billions)
  • Exhibit 18: Segmentation of global tissue sealants market by type 2015
  • Exhibit 19: Categorization of fibrin sealants
  • Exhibit 20: Categorization of synthetic sealants
  • Exhibit 21: Segmentation of global hemostats and tissue sealants market by geography 2015
  • Exhibit 22: Segmentation of global hemostats and tissue sealants market by geography 2020
  • Exhibit 23: Segmentation of global hemostats and tissue sealants market by geography 2015-2020
  • Exhibit 24: Hemostats and tissue sealants market in Americas 2015-2020 ($ billions)
  • Exhibit 25: Hemostats and tissue sealants market in EMEA 2015-2020 ($ billions)
  • Exhibit 26: Segmentation of hemostats and tissue sealants market in Europe 2015
  • Exhibit 27: Hemostats and tissue sealants market in APAC 2015-2020 ($ millions)
  • Exhibit 28: Impact of drivers
  • Exhibit 29: Impact of drivers and challenges
  • Exhibit 30: Ranking of vendors in global hemostats market 2015
  • Exhibit 31: Ranking of vendors in global tissue sealants market 2015
  • Exhibit 32: Advanced Medical Solutions Group: Product portfolio
  • Exhibit 33: Advanced Medical Solutions Group: Branded Direct segment by revenue 2013-2015 ($ millions)
  • Exhibit 34: Advanced Medical Solutions Group: Key takeaways
  • Exhibit 35: Baxter International: Key takeaways
  • Exhibit 36: Product group category
  • Exhibit 37: C. R. Bard: Product portfolio
  • Exhibit 38: C.R. Bard: Surgical specialty product segment by revenue 2013-2015 ($ millions)
  • Exhibit 39: C. R. Bard: Key takeaways
  • Exhibit 40: CryoLife: Key takeaways
  • Exhibit 41: CSL Behring: Key takeaways
  • Exhibit 42: Imtegra LifeSciences: Product segmentation
  • Exhibit 43: Integra LifeSciences: Product portfolio
  • Exhibit 44: Integra LifeSciences: Orthopedics and tissue technologies segment by revenue 2013-2015 ($ millions)
  • Exhibit 45: Integra LifeSciences :Key takeaways
  • Exhibit 46: Johnson & Johnson (Ethicon): Key takeaways
  • Exhibit 47: Other prominent vendors
Back to Top